Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies
Само за регистроване кориснике
2020
Конференцијски прилог (Објављена верзија)
Метаподаци
Приказ свих података о документуИзвор:
3rd Meeting of the European Research Network on Signal Transduction (ERNEST COST Action CA18133), Signal transduction: From the genomic to the systems level (and everything in between), October 12-14, 2020, Abstract Booklet, 2020, 75-75Издавач:
- European Research Network on Signal Transduction (ERNEST) CA18133
Финансирање / пројекти:
- Синтеза, квантитативни однос између структуре и дејства, физичко-хемијска карактеризација и анализа фармаколошки активних супстанци (RS-MESTD-Basic Research (BR or ON)-172033)
Институција/група
PharmacyTY - CONF AU - Radan, Milica AU - Ružić, Dušan AU - Antonijević, Mirjana AU - Đikić, Teodora AU - Nikolić, Katarina PY - 2020 UR - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4873 PB - European Research Network on Signal Transduction (ERNEST) CA18133 C3 - 3rd Meeting of the European Research Network on Signal Transduction (ERNEST COST Action CA18133), Signal transduction: From the genomic to the systems level (and everything in between), October 12-14, 2020, Abstract Booklet T1 - Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies SP - 75 EP - 75 UR - https://hdl.handle.net/21.15107/rcub_farfar_4873 ER -
@conference{ author = "Radan, Milica and Ružić, Dušan and Antonijević, Mirjana and Đikić, Teodora and Nikolić, Katarina", year = "2020", publisher = "European Research Network on Signal Transduction (ERNEST) CA18133", journal = "3rd Meeting of the European Research Network on Signal Transduction (ERNEST COST Action CA18133), Signal transduction: From the genomic to the systems level (and everything in between), October 12-14, 2020, Abstract Booklet", title = "Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies", pages = "75-75", url = "https://hdl.handle.net/21.15107/rcub_farfar_4873" }
Radan, M., Ružić, D., Antonijević, M., Đikić, T.,& Nikolić, K.. (2020). Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies. in 3rd Meeting of the European Research Network on Signal Transduction (ERNEST COST Action CA18133), Signal transduction: From the genomic to the systems level (and everything in between), October 12-14, 2020, Abstract Booklet European Research Network on Signal Transduction (ERNEST) CA18133., 75-75. https://hdl.handle.net/21.15107/rcub_farfar_4873
Radan M, Ružić D, Antonijević M, Đikić T, Nikolić K. Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies. in 3rd Meeting of the European Research Network on Signal Transduction (ERNEST COST Action CA18133), Signal transduction: From the genomic to the systems level (and everything in between), October 12-14, 2020, Abstract Booklet. 2020;:75-75. https://hdl.handle.net/21.15107/rcub_farfar_4873 .
Radan, Milica, Ružić, Dušan, Antonijević, Mirjana, Đikić, Teodora, Nikolić, Katarina, "Discovery of new 5-HT2A receptor antagonists with a strategy of combining ligand and target-based drug design methodologies" in 3rd Meeting of the European Research Network on Signal Transduction (ERNEST COST Action CA18133), Signal transduction: From the genomic to the systems level (and everything in between), October 12-14, 2020, Abstract Booklet (2020):75-75, https://hdl.handle.net/21.15107/rcub_farfar_4873 .